BlackThorn Therapeutics
Transforming lives with neurobehavioral therapies
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- blackthornrx.com
- Total Funding
- $130.0M
- Last Round
- $76.0M Series BJun 2019
About
BlackThorn Therapeutics was a clinical-stage biopharmaceutical company dedicated to developing novel treatments for neurobehavioral disorders using its INFORM platform linking brain physiology to behavior. Founded in 2014 by Alex Tkachenko and Ed Roberts in San Francisco, the company raised $130M across four rounds including a $76M Series B. BlackThorn was later rebranded as Neumora Therapeutics, advancing its lead NOPR antagonist program into Phase 2 clinical trials.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account